Conversely, increased SMPDL3b levels were shown to prevent suPAR-αVβ3 interaction in DKD, thus preventing podocyte cytoskeleton remodeling and migration, while leading to an increase in RhoA kinase activity [124,134,142,145,146]. The gene discussed is SMPDL3B; the disease is diabetic kidney disease.